RSC Advances · 2024 · 12 citations · 22 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryTargeted Drug DeliveryTumor MicroenvironmentHydrogel BiomaterialsHydrogelsMacrophage BiologyTargeted Cancer TherapyTargeted TherapyTumor-associated MacrophagesCancer-associated MacrophagesDrug Delivery HydrogelsHydrogel FormulationsHydrogel-based DeliveryM2 Macrophage PhenotypesMacrophage ImmunomodulationMacrophage-targeted TherapeuticsSwelling
cells per mL) and have a higher swelling (≈250-280%). This study indicates that ZM-based hydrogel could be a potential drug carrier (Rifampicin and Levofloxacin) for targeting tumour-associated macrophages (M2).
22